A Study Of Relatlimab Plus Nivolumab In Combination With Chemotherapy Vs. Nivolumab In Combination With Chemotherapy In Participants With Stage IV Or Recurrent NSCLC Read more
A Randomized Phase 3 Study Of Sitravatinib In Combination With Nivolumab Versus Docetaxel In Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On Or After Platinum-Based Chemotherapy In Combination With Checkpoint Inhibitor Therapy Read more
Phase IV Observational Study To Collect Safety And Outcome Data In Real-World Setting In Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca (EMERGE 402) Read more
A Phase 2 Randomized, Double-Blind, Clinical Trial Of Trilaciclib Versus Placebo In Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Treated With Docetaxel In The 2nd/3rd Line Setting (PRESERVE 4) Read more
A Phase I Multi-Dose Study Of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) In Adults With Actively Diagnosed Primary Or Secondary Acute Myeloid Leukemia (AML) In Morphologic Complete Remission With Minimal Residual Disease (MRD) Read more
A Randomized, Controlled Phase 3 Study Of Pacritinib Versus Physician’s Choice In Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Or Post-Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Count <50,000/Ìl)(PACIFICA) Read more
Individual Patient Supply Of Oral Pacritinib In A Patient With Thrombocytopenia And Primary Myelofibrosis. Read more
A Phase 1, First-In-Human, Dose Escalation Study Of JNJ-67571244 (Bispecific Antibody Targeting CD33 And CD3) In Subjects With Relapsed Or Refractory Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS) Read more
V-FAST: A Phase 1b Master Trial To Investigate CPX-351 Combined With Various Targeted Agents In Subjects With Previously Untreated Acute Myeloid Leukemia Read more
